Delivery Order SPE2DB25D3109-SPE2DB25FPJUF

Award Date 1/21/25
Potential Completion Date 1/22/25
Potential Value $4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of the pharmaceutical product LO LOESTRIN FE 1-10 TABLET 28S to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $1,098.24, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of October 24, 2024. The award is part of a larger Indefinite Delivery Contract...
This federal contract award, valued at $2,277.33, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is a delivery order for the supply of LO LOESTRIN FE 1-10 TABLET 28S, a pharmaceutical product. The contract has an ultimate completion date of January 28, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, valued at $2,409.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the pharmaceutical product LO LOESTRIN FE 1-10 TABLET 28S, with a period of performance through February 20, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,844.02 firm fixed-price delivery order is for the supply of LO LOESTRIN FE 1-10 TABLET 28S, a prescription medication. The contract has an ultimate completion date of July 22, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This federal contract award, valued at $3,650.99, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract is a delivery order for LO LOESTRIN FE 1-10 TABLET 28S, a type of oral contraceptive medication. The contract has an ultimate completion date of January 14, 2025 and uses a firm fixed price pricing structure. This award is part of a larger Indefinite Delivery Contract (IDC) valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,613.57 firm fixed-price delivery order is for the supply of LO LOESTRIN FE 1-10 TABLET 28S, a pharmaceutical product, with a completion date of May 29, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $2,701.24, is for the delivery of LO LOESTRIN FE 1-10 TABLET 28S, a prescription pharmaceutical product. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at...
This federal contract award, with a ceiling value of $2,112.38, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the pharmaceutical product "LO LOESTRIN FE 1-10 TABLET 28S" and has an ultimate completion date of December 12, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The $6,093.99 firm fixed-price contract is for the supply of the pharmaceutical product LO LOESTRIN FE 1-10 TABLET 28S. This delivery order is part of a $999,999,999 IDC with the DLA that provides a comprehensive range of pharmaceutical and medical products to support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,553.96 firm fixed-price delivery order is for the medical product "LO LOESTRIN FE 1-10 TABLET 28S" and has an ultimate completion date of July 26, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
  • SPE2DB25D3109
    Indefinite Delivery Contract
  • SPE2DB25D3109-SPE2DB25FPJUF
    Delivery Order

This federal contract award, valued at $3,960.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the pharmaceutical product "LO LOESTRIN FE 1-10 TABLET 28S" with an ultimate completion date of January 22, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 4/27/25, 12:55 AM